Skin and Joints Podcast

My Real World Experience Managing Psoriasis with Dr.Christina Han

Episode Summary

There's a new Sheriff in town-well maybe 2! This episode explores deep insights into the mind of Vancouver based dermatologist and Clinical Assistant Professor of Medicine, Dr.Christina Han exploring key, real-world considerations for practically assessing and managing patients with moderate to severe plaque psoriasis, barriers she finds in the patient journey, and the opportunities for multidisciplinary care. We explore her use of 2 targeted biologic therapies, ixekizumab (Taltz) and Guselkumab (Tremfya): how they perform in the real world setting, 𝘄𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻𝘀 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁'𝘀 𝗷𝗼𝘂𝗿𝗻𝗲𝘆, and dare we say, how they stack up against each other. Dr.Han reveals a secret talent as well.

Episode Notes

Episode Learning Objectives

Discuss appropriate assessment strategies for disease activity and prognosis to guide treatment decisions for moderate to severe plaque psoriasis
Apply current evidence and guidelines on targeted biologics with shared decision-making to make effective individualized treatment decisions for patients with moderate-to-severe plaque PsO (specifically ixekizumab and Guselkumab)
Implement evidence-based and expert consensus strategies to improve interprofessional care coordination and address the needs of patients with comorbidities

ABOUT DR.CHRISTINA HAN, MD, FRCPC:

Dr. Christina Han is a dermatologist practicing medical and surgical dermatology in Vancouver, BC and is certified to practice in both the United States and Canada. She sees a broad range of dermatology patients, including pediatric and adults and focuses her practice on medical dermatology. Her clinical focus includes inflammatory conditions, including psoriasis, atopic dermatitis, and acne. She also teaches medical students and residents and is a Clinical Assistant Professor with the Department of Dermatology at UBC.

Disclaimer: This is an educational podcast only and does not replace professional medical advice. Please consult your healthcare provider for any health issues.

Supported by IMEs from Janssen and Lilly